Generated by AI
PharmaCyte Biotech, Inc. is a clinical-stage biotechnology company focused on developing cellular therapies for cancer and diabetes. Its core platform is Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology designed to support therapies for difficult-to-treat conditions, including inoperable pancreatic cancer and other solid tumors. The company’s work centers on applying this platform to create treatment candidates that protect and deliver living cells in a controlled way. PharmaCyte Biotech is also active in related areas such as malignant ascites, reflecting a broader focus on oncology and metabolic disease applications. Headquartered in Las Vegas, Nevada, PharmaCyte Biotech operates as a research-driven company in the health technology sector, with its current business concentrated on advancing product development and commercialization efforts in specialized cellular medicine.
Website3960 Howard Hughes Parkway
Las Vegas, NV, 89169
United States
Summary of Sep 16's posts. Generated by AI.
Summary of Dec 8's posts. Generated by AI.
Summary of Sep 16's posts. Generated by AI.
Investors talking about PMCB also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.